phaware®

@phaware

Pulmonary hypertension is a rare disease affecting the arteries of the lungs that can lead to right heart failure Burbank, CA

info@phaware.global
Vrijeme pridruživanja: lipanj 2014.

Tweetovi

Blokirali ste korisnika/cu @phaware

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @phaware

  1. Prikvačeni tweet
    prije 5 sati

    United Therapeutics is conducting the BREEZE Study which is investigating a way to deliver the same medication (treprostinil) that you know as Tyvaso with a much smaller device. Learn more: or refer to NCT03950739 on

    Poništi
  2. 31. sij

    "My husband and I, from day one of Madison's diagnosis, started journaling about PH. That became an open book for us. Our CaringBridge journal is very much a teaching tool for everybody in our lives. ." - Cheryl Wegener interview 307

    Poništi
  3. 30. sij

    "My husband and I, from day one of Madison's diagnosis, started journaling about PH. That became an open book for us. Our CaringBridge journal is very much a teaching tool for everybody in our lives. ." - Cheryl Wegener podcast Ep 307

    Poništi
  4. 28. sij

    "I remember my first time at a [PH Conference]. It was so nice seeing someone else with it, to have someone who knows what you're going through." - Madison Wegener interview 306

    Poništi
  5. 27. sij

    "I remember my first time at a [PH Conference]. It was so nice seeing someone else with it, to have someone who knows what you're going through." - Madison Wegener podcast Ep 306

    Poništi
  6. 19. sij

    We are heartbroken to learn that our friend Madison lost her battle with PH. Re-sharing one of our first podcast interviews when we met Madison and her amazing parents Cheryl and Robert Wegener back in 2016.

    Poništi
  7. 17. sij

    Today is the 3 year anniversary of Iain Hess' lung transplant surgery. Listen to his amazing story...

    Poništi
  8. 15. sij

    Bay Area PAH Patients! LAST CHANCE to register! You are invited to participate in this local 1 on 1 study happening on JAN 16-17 & JAN 20-21. SPECIFICALLY SEEKING NON-HISPANIC MALES (IF POSSIBLE) RSVP: 408-780-1761 email: iaaresearch@gmail.com

    Poništi
  9. 15. sij

    Long Beach Area PAH Patients! LAST CHANCE to register! You are invited to participate in this local 1 on 1 study happening on JAN 23-27th near the Long Beach Airport. SPECIFICALLY SEEKING NON-HISPANIC MALES (IF POSSIBLE) RSVP:408-780-1761 email: iaaresearch@gmail.com

    Poništi
  10. proslijedio/la je Tweet
    7. sij

    Our team was there, and it was a fabulous event. Thank you so much for participating and thanks also to for hosting. Such a great cause.

    Poništi
  11. proslijedio/la je Tweet
    7. sij

    Bay Area PAH Patients: Participate in a local 1 on 1 study happening in JAN 16-17 & JAN 20-21. Seeking patients on Tyvaso but you may qualify as a non-inhaled patient, too. Receive $250 or $350 for participating, but you must RSVP: Contact: 408-780-1761 or iaaresearch@gmail.com

    Poništi
  12. 7. sij

    Bay Area PAH Patients: Participate in a local 1 on 1 study happening in JAN 16-17 & JAN 20-21. Seeking patients on Tyvaso but you may qualify as a non-inhaled patient, too. Receive $250 or $350 for participating, but you must RSVP: Contact: 408-780-1761 or iaaresearch@gmail.com

    Poništi
  13. proslijedio/la je Tweet
    26. pro 2019.

    wants to share YOUR story to over 110 countries across the world! We are currently interviewing patients, caregivers, & medical professionals for season 4 of our podcast series. Share your RARE: info@phaware.global

    Poništi
  14. proslijedio/la je Tweet
    26. pro 2019.

    PB1046, a long-acting VIP analogue, is currently being evaluated in a Phase 2b clinical trial in PAH patients. -

    Poništi
  15. proslijedio/la je Tweet
    31. pro 2019.
    Poništi
  16. 31. pro 2019.
    Poništi
  17. 26. pro 2019.

    PB1046, a long-acting VIP analogue, is currently being evaluated in a Phase 2b clinical trial in PAH patients. -

    Poništi
  18. 26. pro 2019.

    wants to share YOUR story to over 110 countries across the world! We are currently interviewing patients, caregivers, & medical professionals for season 4 of our podcast series. Share your RARE: info@phaware.global

    Poništi
  19. proslijedio/la je Tweet
    23. pro 2019.

    Congrats to and all who were involved for their work developing and launching the first Global Pulmonary Arterial Hypertension () Patient Charter. . Read the charter here:

    Poništi
  20. 22. pro 2019.

    phaware global association® is excited to announce the launch of the first Global Pulmonary Arterial Hypertension (PAH) Patient Charter. Learn more:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·